第十一届董事会 2025 年第五次临时会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 股票代码：000686 股票简称：东北证券 公告编号：2025-044 东北证券股份有限公司 一、董事会会议召开情况 1.东北证券股份有限公司第十一届董事会 2025 年第五次临时会议于 2025 年 7 月 31 日以现场和视频会议结合的方式召开，会议召开地点为吉林省长春市 生态大街 6666 号东北证券股份有限公司 1118 会议室。 2.公司全体董事一致同意豁免本次会议提前通知的义务，同意在 2025 年 7 月 31 日公司 2025 年第二次临时股东大会结束后召开本次会议。 3.会议应出席董事 13 人，实际出席并参加表决的董事 13 人。其中，现场参 会董事 10 人，视频参会董事 1 人，授权委托参会董事 2 人，其中：独立董事李 东方先生以视频方式参会，董事于来富先生因公务原因书面委托董事刘树森先生 代为出席并代为行使表决权，董事邢中成先生因公务原因书面委托董事刘继新先 生代为出席并代为行使表决权。 4.会议召集人和主持人：公司董事长李福春先生。 ...

Core Viewpoint - Northeast Securities maintains an "overweight" rating on Yidu Tech (02158), highlighting significant improvements in market penetration in the medical intelligence sector and record-high gross margins for its self-developed i-series solutions during the fiscal year 2025 [1] Group 1: Market Penetration and Client Base - As of March 31, 2025, the company's big data platform serves 110 top hospitals in China and 44 regulatory agencies, covering over 4,000 hospitals [1] - The Copilot product matrix has been deployed in over 30 tertiary hospitals within three months, creating a complete closed loop of "data governance - intelligent training - scenario implementation," significantly enhancing market penetration in the medical intelligence field [1] - The life sciences segment has served 132 clients, with a revenue retention rate of 87.51% among the top 20 clients, 16 of which are multinational pharmaceutical companies [1] Group 2: Financial Performance and Competitive Edge - The self-developed i-series solutions cover the entire lifecycle of drug development, including clinical development, research design, and commercial risk assessment, with gross margins reaching 33.5%, a historical high, showcasing the company's core competitiveness in pharmaceutical R&D intelligence [1] - The company has been the main operating platform for "Shenzhen Huimin Insurance" for three consecutive years, with 6.09 million insured individuals in 2024, and has operated "Beijing Huimin Insurance" for four years, accumulating over 15 million insured instances [1] - The platform has over 24 million active users, all of whom have completed at least one transaction, indicating strong user reach and market acceptance of health management services, laying a solid foundation for future commercialization [1]

Core Viewpoint - Northeast Securities maintains an "overweight" rating for Yidu Technology (02158), highlighting significant improvements in market penetration in the medical intelligence sector and record-high gross margins for its self-developed i-series solutions during the fiscal year 2025 [1] Group 1: Market Penetration and Client Base - As of March 31, 2025, the company's big data platform serves 110 top hospitals in China and 44 regulatory agencies, covering over 4000 hospitals [1] - The Copilot product matrix completed deployments in over 30 tier-one hospitals within three months, creating a complete closed loop of "data governance - intelligent training - scenario implementation," significantly enhancing market penetration in medical intelligence [1] - The life sciences segment serves 132 clients, with a revenue retention rate of 87.51% among the top 20 clients, 16 of which are multinational pharmaceutical companies [1] Group 2: Financial Performance and Competitive Edge - The gross margin for the self-developed i-series solutions reached 33.5%, marking a historical high and underscoring the company's core competitiveness in the field of pharmaceutical research and development intelligence [1] - The company has been the main operating platform for "Shenzhen Huimin Insurance" for three consecutive years, with 6.09 million insured individuals in 2024; it has also operated "Beijing Huimin Insurance" for four years, accumulating over 15 million insured instances [1] - The platform has over 24 million active users, all of whom have completed at least one transaction, demonstrating strong user reach and market acceptance for health management services, laying a solid foundation for future commercialization [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或者重大 遗漏。 一、召开会议的基本情况 1.会议届次：公司2025年第二次临时股东大会 2.会议召集人：公司董事会。公司第十一届董事会2025年第四次临时会议审议通过了关于提议召开本次 股东大会的议案。 3.会议召开的合法、合规性：本次会议召开符合法律法规、深交所业务规则和《公司章程》的规定。 登录新浪财经APP 搜索【信披】查看更多考评等级 4.会议召开的日期、时间： （1）现场会议时间：2025年7月31日（星期四）14:30时。 （2）网络投票时间：通过深圳证券交易所交易系统投票的时间为2025年7月31日（星期四）上午9:15- 9:25，9:30-11:30，下午13:00-15:00；通过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn） 进行投票的时间为2025年7月31日（星期四）9:15-15:00期间的任意时间。 5.会议召开方式：本次股东大会采取现场表决与网络投票相结合的方式召开。 公司股东应选择现场 ...

Meeting Information - The second extraordinary general meeting of shareholders for 2025 will be held on July 31, 2025, at 14:30 [1] - Shareholders can vote through the Shenzhen Stock Exchange trading system and internet voting system on the same day [4][5] - The record date for shareholders to attend the meeting is July 24, 2025 [1] Voting Procedures - Shareholders must choose either on-site voting or internet voting, with duplicate votes being invalidated [1] - Natural person shareholders need to present valid identification and stock account cards for registration [3] - Proxy representatives must provide authorization documents and identification [3] Agenda Items - The meeting will review proposals, including the election of non-independent directors [2][9] - Cumulative voting will be used for the election, allowing shareholders to allocate their votes among candidates [5][9] Contact Information - The contact persons for the meeting are Han Peixuan and Liu Hongyu [3] - The company is located at 6666 Ecological Avenue, Changchun, Jilin Province, with a postal code of 130119 [4]

股票代码：000686 股票简称：东北证券 公告编号：2025-042 东北证券股份有限公司 关于召开 2025 年第二次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、召开会议的基本情况 1.会议届次：公司 2025 年第二次临时股东大会 2.会议召集人：公司董事会。公司第十一届董事会 2025 年第四次临时会议 审议通过了关于提议召开本次股东大会的议案。 3.会议召开的合法、合规性：本次会议召开符合法律法规、深交所业务规则 和《公司章程》的规定。 4.会议召开的日期、时间： 1 （2）公司董事、监事和高级管理人员； （1）现场会议时间：2025 年 7 月 31 日（星期四）14:30 时。 （2）网络投票时间：通过深圳证券交易所交易系统投票的时间为 2025 年 7 月 31 日（星期四）上午 9:15-9:25，9:30-11:30，下午 13:00-15:00；通过深圳 证券交易所互联网投票系统（http://wltp.cninfo.com.cn）进行投票的时间为 2025 年 7 月 31 日（星期四）9:15-15 ...

Group 1: ETF Market Overview - As of the end of June, the total number of ETFs in the Shanghai Stock Exchange reached 701 with a total market value exceeding 3.14 trillion yuan, while the Shenzhen Stock Exchange had 495 ETFs with a total market value over 1.15 trillion yuan, bringing the combined total to over 4.3 trillion yuan, showing a steady increase from the previous month [1] - The first batch of 10 science and technology innovation bond ETFs was launched on July 17, attracting significant market attention and reshaping the bond ETF market landscape, indicating a promising future for this segment [1] Group 2: Brokerage Business Insights - In June, the top five brokerages by trading volume for Shanghai ETFs were Huatai Securities, CITIC Securities, Guotai Junan, Dongfang Securities, and China Galaxy, with market shares of 11.75%, 11.04%, 6.55%, 5.30%, and 4.71% respectively [2] - The leading brokerages by ETF holdings in Shanghai as of the end of June were China Galaxy, Shenwan Hongyuan, CITIC Securities, Guotai Junan, and招商证券, with market shares of 24.03%, 17.61%, 6.26%, 4.78%, and 4.63% respectively [2] Group 3: Growth of Bond ETFs - The domestic ETF market expanded by nearly 580 billion yuan in the first half of the year, with bond ETFs and Hong Kong stock ETFs being the main contributors, highlighting a growing interest in these products [3] - The number of bond ETFs increased from 21 to 29, while the total market size of bond ETFs reached 218.1 billion yuan by the end of the first quarter of 2025, indicating a rising acceptance of index-based bond products among investors [4]

Core Viewpoint - Northeast Securities Co., Ltd. has successfully issued a short-term corporate bond (Phase V) aimed at professional investors, with a total issuance scale of up to RMB 10 billion, reflecting strong market demand and investor confidence [2][3]. Summary by Sections Issuer Information - The issuer is Northeast Securities Co., Ltd., which has received approval from the China Securities Regulatory Commission for the issuance of short-term corporate bonds [2]. Bond Issuance Details - The total issuance scale for this bond is capped at RMB 10 billion, with a face value of RMB 100 per bond [2]. - The issuance period is set from July 25, 2025, to July 28, 2025 [2]. - The bond's coupon rate is established at 1.70%, and the subscription multiple reached 2.21 times, indicating strong interest from investors [2][3]. Investor Compliance - All investors participating in the bond issuance meet the regulatory requirements outlined in various management and trading guidelines [3].

东北证券股份有限公司2025年面向专业投资者公开发行短期公 司债券（第五期）发行结果公告 发行人及其全体董事、监事、高级管理人员或履行同等职责的人员保证公告 内容真实、准确和完整，并对公告中的虚假记载、误导性陈述或者重大遗漏承担 责任。 东北证券股份有限公司（以下简称"发行人"）公开发行不超过人民币50亿 元的短期公司债券已获得中国证券监督管理委员会证监许可〔2024〕1732号注册。 根据《东北证券股份有限公司2025年面向专业投资者公开发行短期公司债券（第 五期）发行公告》，东北证券股份有限公司2025年面向专业投资者公开发行短期 公司债券（第五期）（以下简称"本期债券"）发行规模为不超过人民币10亿元（含）， 发行价格为每张100元，采取网下面向专业机构投资者询价配售的方式发行。 本期债券发行时间自2025年7月25日至2025年7月28日，具体发行情况如下： 1、网下发行 证券代码：524379.SZ 证券简称：25东北D5 1 知》等各项有关要求。 特此公告。 本期债券网下预设的发行数量占本期债券发行规模的比例为100%，即不超 过10亿元（含10亿元）；最终网下实际发行数量为10亿元，占本期债券发 ...

Core Viewpoint - The brokerage sector in A-shares is experiencing significant growth, with the brokerage index rising over 25% since April 8, and many brokerages reporting substantial increases in net profit for the first half of the year, driven by a recovering capital market and favorable policies [1][2][3][8]. Performance Summary - At least 28 listed brokerages have released performance forecasts for the first half of the year, with most reporting a year-on-year net profit growth exceeding 50%, and some large brokerages, such as Shenwan Hongyuan and Guotai Junan, expecting over 100% growth [2][5][6]. - The overall increase in brokerage performance is attributed to the active trading environment in the capital market, which has significantly boosted self-operated investment income and brokerage fee income [8][9]. Factors Supporting Growth - **Fundamental Support**: The active trading environment is expected to continue benefiting brokerage performance, with most brokerages forecasting net profit growth of over 50% for the second half of the year [3][13]. - **Capital Support**: The allocation of equity funds to non-bank financials has increased slightly, indicating potential for further investment in brokerages [14]. - **Policy Support**: Recent policy changes encourage brokerages to focus on improving return on equity (ROE), which may enhance their performance [15]. - **Valuation Levels**: Most brokerages have a price-to-book ratio just above 1, with only about 10 listed brokerages exceeding a ratio of 2, suggesting room for valuation growth [16]. Dividend Yield and Valuation - Several brokerages offer dividend yields above 2%, which is higher than the yield on 10-year government bonds, making them attractive for income-focused investors [1][16][18].